These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24054565)

  • 1. Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks.
    Pivetta T; Isaia F; Trudu F; Pani A; Manca M; Perra D; Amato F; Havel J
    Talanta; 2013 Oct; 115():84-93. PubMed ID: 24054565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
    Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
    J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH; Jollow DJ; Stuart RK
    Cancer Res; 1991 May; 51(10):2536-41. PubMed ID: 2021933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
    Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
    J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.
    Deegan C; Coyle B; McCann M; Devereux M; Egan DA
    Chem Biol Interact; 2006 Dec; 164(1-2):115-25. PubMed ID: 17030029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and sample size for evaluating combinations of drugs of linear and loglinear dose-response curves.
    Fang HB; Tian GL; Li W; Tan M
    J Biopharm Stat; 2009 Jul; 19(4):625-40. PubMed ID: 20183430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines.
    Mineura K; Kowada M
    Cell Biol Int; 1996 May; 20(5):355-7. PubMed ID: 8688852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probenecid is a chemosensitizer in cancer cell lines.
    Campos-Arroyo D; Martínez-Lazcano JC; Melendez-Zajgla J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):495-504. PubMed ID: 21861129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of trimetrexate cytotoxicity in vitro and in vivo by carboxypeptidase G2.
    Romanini A; Sobrero AF; Chou TC; Sherwood RF; Bertino JR
    Cancer Res; 1989 Nov; 49(21):6019-23. PubMed ID: 2529027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
    Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2.
    Rudzok S; Schlink U; Herbarth O; Bauer M
    Toxicol Appl Pharmacol; 2010 May; 244(3):336-43. PubMed ID: 20132835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neighbor communities in drug combination networks characterize synergistic effect.
    Zou J; Ji P; Zhao YL; Li LL; Wei YQ; Chen YZ; Yang SY
    Mol Biosyst; 2012 Oct; 8(12):3185-96. PubMed ID: 23014807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
    Wu XX; Kakehi Y
    Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of ICI 182,780 on the cytotoxicity of cisplatin in cervical carcinoma cell lines.
    García-López P; Rodríguez-Dorantes M; Pérez-Cárdenas E; Cerbón M; Mohar-Betancourt A
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):533-40. PubMed ID: 15138713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells.
    Frost P; Abbruzzese JL; Hunt B; Lee D; Ellis M
    Cancer Res; 1990 Aug; 50(15):4572-7. PubMed ID: 1695122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.